ASH-话题@MedSci

#ASH#

242篇内容 | 2148人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1301178, encodeId=ef3a13011e8e1, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=[ASH2016]滤泡淋巴瘤治疗研究进展, objectType=article, longId=90213, objectId=c94090213a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c94090213a7, replyNumber=0, likeNumber=56, createdTime=2017-03-02, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c94090213a7, moduleTitle=[ASH2016]滤泡淋巴瘤治疗研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c94090213a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301177, encodeId=a46c13011e73c, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=中国学者发现NASH新靶点，具有重大临床意义, objectType=article, longId=90033, objectId=f3ea9003354, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3ea9003354, replyNumber=0, likeNumber=48, createdTime=2017-02-27, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3ea9003354, moduleTitle=中国学者发现NASH新靶点，具有重大临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3ea9003354)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301176, encodeId=0a1c13011e6c7, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=Nat Med：武汉大学李红良教授发现非酒精性脂肪性肝炎（NASH）关键治疗靶点, objectType=article, longId=89864, objectId=29b28986491, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29b28986491, replyNumber=0, likeNumber=84, createdTime=2017-02-25, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29b28986491, moduleTitle=Nat Med：武汉大学李红良教授发现非酒精性脂肪性肝炎（NASH）关键治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29b28986491)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301175, encodeId=c1a313011e5ac, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=[ASH 2016]B细胞淋巴瘤临床研究进展, objectType=article, longId=88910, objectId=36948891040, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36948891040, replyNumber=0, likeNumber=59, createdTime=2017-02-16, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36948891040, moduleTitle=[ASH 2016]B细胞淋巴瘤临床研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36948891040)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301174, encodeId=8cbb13011e4ec, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2016：Ibrutinib治疗慢性CVHD，疗效如何？, objectType=article, longId=84924, objectId=d30484924e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d30484924e5, replyNumber=0, likeNumber=66, createdTime=2016-12-22, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d30484924e5, moduleTitle=ASH 2016：Ibrutinib治疗慢性CVHD，疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d30484924e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301173, encodeId=3e4313011e3c2, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=药华医药将于ASH年会发表治疗PV新药Proud-PV三期临床试验结果, objectType=article, longId=83296, objectId=dcc38329618, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dcc38329618, replyNumber=0, likeNumber=71, createdTime=2016-12-01, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dcc38329618, moduleTitle=药华医药将于ASH年会发表治疗PV新药Proud-PV三期临床试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dcc38329618)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301172, encodeId=d6f513011e2eb, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=壮士断腕吉利德新药selonsertib舍弃PAH、DKD专注NASH领域研发, objectType=article, longId=80904, objectId=fa9780904d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa9780904d9, replyNumber=0, likeNumber=68, createdTime=2016-10-26, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa9780904d9, moduleTitle=壮士断腕吉利德新药selonsertib舍弃PAH、DKD专注NASH领域研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa9780904d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301171, encodeId=876d13011e154, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=2016SCCM/ASHP/ACCP临床实践指南：维持成人危重患者神经肌肉阻滞发布, objectType=article, longId=80564, objectId=0a3e8056443, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a3e8056443, replyNumber=0, likeNumber=42, createdTime=2016-10-22, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a3e8056443, moduleTitle=2016SCCM/ASHP/ACCP临床实践指南：维持成人危重患者神经肌肉阻滞发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a3e8056443)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301170, encodeId=a76113011e0ab, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=2015BASHH英国指南——HIV暴露后性接触的预防发布, objectType=article, longId=79463, objectId=d24ee94632b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d24ee94632b, replyNumber=0, likeNumber=19, createdTime=2016-10-09, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d24ee94632b, moduleTitle=2015BASHH英国指南——HIV暴露后性接触的预防发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d24ee94632b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301169, encodeId=80d6130116969, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=Ann Intern Med：吡格列酮可改善NASH，阻止2型糖尿病患者的疾病进展, objectType=article, longId=71701, objectId=37a1e1701c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37a1e1701c3, replyNumber=0, likeNumber=53, createdTime=2016-06-29, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37a1e1701c3, moduleTitle=Ann Intern Med：吡格列酮可改善NASH，阻止2型糖尿病患者的疾病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37a1e1701c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301168, encodeId=ea9113011689f, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=PNAS：高转移性肺癌细胞中发现Musashi-2高表达, objectType=article, longId=70362, objectId=3cfce03620c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cfce03620c, replyNumber=0, likeNumber=81, createdTime=2016-06-11, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cfce03620c, moduleTitle=PNAS：高转移性肺癌细胞中发现Musashi-2高表达, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cfce03620c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301167, encodeId=1cba130116eed, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=邴铁军：一个非酒精性脂肪肝（NASH）药物的交易, objectType=article, longId=66511, objectId=b6056651132, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6056651132, replyNumber=0, likeNumber=85, createdTime=2016-04-15, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6056651132, moduleTitle=邴铁军：一个非酒精性脂肪肝（NASH）药物的交易, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6056651132)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301166, encodeId=514a13011662c, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=Am J Gastroenterol：缺乏维生素D会增加NAFLD患者的NASH风险, objectType=article, longId=66102, objectId=a6a76610299, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6a76610299, replyNumber=0, likeNumber=59, createdTime=2016-04-07, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6a76610299, moduleTitle=Am J Gastroenterol：缺乏维生素D会增加NAFLD患者的NASH风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6a76610299)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301165, encodeId=1fc7130116552, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=Stroke：DASH饮食可降低缺血性卒中风险, objectType=article, longId=63267, objectId=18a26326e67, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18a26326e67, replyNumber=0, likeNumber=75, createdTime=2016-02-17, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18a26326e67, moduleTitle=Stroke：DASH饮食可降低缺血性卒中风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18a26326e67)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301164, encodeId=50f8130116482, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2015：癌症相关血栓形成患者使用LMWH治疗6月后，可换为华法林治疗, objectType=article, longId=60717, objectId=681a60e17a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=681a60e17a7, replyNumber=0, likeNumber=60, createdTime=2015-12-18, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=681a60e17a7, moduleTitle=ASH 2015：癌症相关血栓形成患者使用LMWH治疗6月后，可换为华法林治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=681a60e17a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301161, encodeId=496d1301161f3, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2015：抗癌新药Kyprolis有望作为多发性骨髓瘤主要治疗药物, objectType=article, longId=60414, objectId=9c9160414cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c9160414cf, replyNumber=0, likeNumber=92, createdTime=2015-12-10, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c9160414cf, moduleTitle=ASH 2015：抗癌新药Kyprolis有望作为多发性骨髓瘤主要治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c9160414cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301162, encodeId=fb90130116277, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2015：免疫调节单抗elotuzumab持续改善多发性骨髓瘤无进展生存期, objectType=article, longId=60415, objectId=514f6041501, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=514f6041501, replyNumber=0, likeNumber=69, createdTime=2015-12-10, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=514f6041501, moduleTitle=ASH 2015：免疫调节单抗elotuzumab持续改善多发性骨髓瘤无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=514f6041501)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301163, encodeId=5c49130116382, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2015：Gazyva联合苯丁酸氮芥一线治疗CLL后4年内无需治疗, objectType=article, longId=60416, objectId=efc1604161b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efc1604161b, replyNumber=0, likeNumber=111, createdTime=2015-12-10, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efc1604161b, moduleTitle=ASH 2015：Gazyva联合苯丁酸氮芥一线治疗CLL后4年内无需治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efc1604161b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301160, encodeId=cf971301160f4, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2015：疫苗接种新策略可降低癌症患者流感风险, objectType=article, longId=60389, objectId=72df60389d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72df60389d3, replyNumber=0, likeNumber=72, createdTime=2015-12-09, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72df60389d3, moduleTitle=ASH 2015：疫苗接种新策略可降低癌症患者流感风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72df60389d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301159, encodeId=a40f1301159fb, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2015：癌症相关血栓患者使用华法林也是安全的, objectType=article, longId=60335, objectId=f1dc603355d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1dc603355d, replyNumber=0, likeNumber=54, createdTime=2015-12-08, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1dc603355d, moduleTitle=ASH 2015：癌症相关血栓患者使用华法林也是安全的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1dc603355d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASH

2020-05-29

kksonne (审核中...)

前往app查看评论内容

#ASH#

[ASH2016]滤泡淋巴瘤治疗研究进展

2017-03-02

kksonne (审核中...)

前往app查看评论内容

#ASH#

中国学者发现NASH新靶点，具有重大临床意义

2017-02-27

kksonne (审核中...)

前往app查看评论内容

#ASH#

Nat Med：武汉大学李红良教授发现非酒精性脂肪性肝炎（NASH）关键治疗靶点

2017-02-25

kksonne (审核中...)

前往app查看评论内容

#ASH#

[ASH 2016]B细胞淋巴瘤临床研究进展

2017-02-16

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2016：Ibrutinib治疗慢性CVHD，疗效如何？

2016-12-22

kksonne (审核中...)

前往app查看评论内容

#ASH#

药华医药将于ASH年会发表治疗PV新药Proud-PV三期临床试验结果

2016-12-01

kksonne (审核中...)

前往app查看评论内容

#ASH#

壮士断腕吉利德新药selonsertib舍弃PAH、DKD专注NASH领域研发

2016-10-26

kksonne (审核中...)

前往app查看评论内容

#ASH#

2016SCCM/ASHP/ACCP临床实践指南：维持成人危重患者神经肌肉阻滞发布

2016-10-22

kksonne (审核中...)

前往app查看评论内容

#ASH#

2015BASHH英国指南——HIV暴露后性接触的预防发布

2016-10-09

kksonne (审核中...)

前往app查看评论内容

#ASH#

Ann Intern Med：吡格列酮可改善NASH，阻止2型糖尿病患者的疾病进展

2016-06-29

kksonne (审核中...)

前往app查看评论内容

#ASH#

PNAS：高转移性肺癌细胞中发现Musashi-2高表达

2016-06-11

kksonne (审核中...)

前往app查看评论内容

#ASH#

邴铁军：一个非酒精性脂肪肝（NASH）药物的交易

2016-04-15

kksonne (审核中...)

前往app查看评论内容

#ASH#

Am J Gastroenterol：缺乏维生素D会增加NAFLD患者的NASH风险

2016-04-07

kksonne (审核中...)

前往app查看评论内容

#ASH#

Stroke：DASH饮食可降低缺血性卒中风险

2016-02-17

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2015：癌症相关血栓形成患者使用LMWH治疗6月后，可换为华法林治疗

2015-12-18

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2015：抗癌新药Kyprolis有望作为多发性骨髓瘤主要治疗药物

2015-12-10

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2015：免疫调节单抗elotuzumab持续改善多发性骨髓瘤无进展生存期

2015-12-10

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2015：Gazyva联合苯丁酸氮芥一线治疗CLL后4年内无需治疗

2015-12-10

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2015：疫苗接种新策略可降低癌症患者流感风险

2015-12-09

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2015：癌症相关血栓患者使用华法林也是安全的

2015-12-08

科室
- - 订阅+
  - 更多科室
工具
服务